Cancer Research Communications Journal Issues Research Articles in November 2024 Edition
November 27, 2024
November 27, 2024
PHILADELPHIA, Pennsylvania, Nov. 27 -- Cancer Research Communications, a peer-reviewed journal from the American Association for Cancer Research that says it stimulates innovation in cancer science and medicine, published research articles on the following topics in its November 2024 edition (Vol. 4, Issue 11):
* Association between Immune-Related Adverse Events and Atezolizumab in Previously Treated Patients with Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer
< . . .
* Association between Immune-Related Adverse Events and Atezolizumab in Previously Treated Patients with Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer
< . . .